ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,312,640 | +19.3% | 1,204,648 | +22.9% | 0.01% | -15.4% |
| Q2 2023 | $3,616,023 | +104.0% | 979,952 | +83.0% | 0.01% | +62.5% |
| Q1 2023 | $1,772,495 | +985.8% | 535,497 | +1172.8% | 0.01% | +700.0% |
| Q4 2022 | $163,243 | -77.1% | 42,073 | -85.6% | 0.00% | -75.0% |
| Q3 2022 | $712,000 | +162.7% | 292,963 | +97.8% | 0.00% | +100.0% |
| Q1 2022 | $271,000 | +84.4% | 148,080 | +41.6% | 0.00% | +100.0% |
| Q4 2021 | $147,000 | +1030.8% | 104,560 | +787.1% | 0.00% | – |
| Q3 2021 | $13,000 | -93.9% | 11,787 | -91.1% | 0.00% | -100.0% |
| Q2 2021 | $212,000 | +231.2% | 132,587 | +266.4% | 0.00% | +100.0% |
| Q1 2021 | $64,000 | -38.5% | 36,190 | +1.7% | 0.00% | -50.0% |
| Q2 2020 | $104,000 | – | 35,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |